Introduction
Artificial insemination with cryopreserved donor semen is an established procedure for childless couples in whom the male partner is subfertile. The British Andrology Society recommends screening potential donors for sexually transmitted infections to minimise the risk Our current guidelines recommend the initial exclusion of donors felt to be at high risk of Of those 109 who were rescreened, 13 had positive findings. Three had genital warts, of whom one also had non-specific urethritis, one had chlamydial urethritis, and three others had non-specific urethritis. Six had asymptomatic urethral carriage of Ureaplasma urealyticum. Other findings included one equivocal chlamydia test (urine EIA positive, DFA negative) and one with equivocal microscopic evidence of non-specific urethritis, both of which were negative on repeat testing of early morning specimens. Another man was named, during his donation period, as a previous consort by a female patient who attended with chlamydial pelvic inflammatory disease. All investigations including serological MIF titres on two occasions failed to show any evidence of chlamydial infection, past or present, and he was allowed to continue as a donor.
At the first screen, the only predictive demographic factor for positive screening findings was a history of more than one partner in the previous 6 Ureaplasma urealyticum is a frequent commensal of the genital tract but may be an important opportunistic pathogen during pregnancy; ureaplasmal chorioamnionitis is associated with prematurity and it may also cause neonatal septicaemia, meningitis, and pneumonia. Screening for Ureaplasma urealyticum in donors is currently rec' -mmended but is not mandatory. In our study, urethral cultures for Ureaplasma were all negative initially with 6/109 (5.5%) positive at rescreening. This finding is considerably lower than in other studies78 and may reflect differences in our population. Four 
